Understanding the mechanisms of frontotemporal lobar degeneration with TDP-43

Human Biomarkers Core

NIH-funded research Stanford University · NIH-10915045

This study is looking into how a protein called TDP-43 causes frontotemporal lobar degeneration, a type of brain disease, and aims to gather helpful information and images of affected brain tissues to better understand the condition and find early signs of it.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionStanford University NIH-funded
Lab location1 site (Stanford, United States)
Project IDNIH-10915045 on NIH RePORTER

What this research studies

This research focuses on unraveling the mechanisms behind frontotemporal lobar degeneration with TDP-43 (FTLD-TDP), a neurodegenerative disease. A diverse team of experts in genetics, neuroscience, and pathology will investigate how dysfunction in TDP-43 may lead to disease progression. They aim to create a centralized resource that provides access to detailed data and images of brain tissues affected by FTLD-TDP, which will help in understanding the disease at a cellular level. By integrating human genetics into their approach, they hope to identify early biomarkers and mechanisms of the disease.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with frontotemporal lobar degeneration or those exhibiting symptoms related to TDP-43 dysfunction.

Not a fit: Patients with other forms of dementia or neurodegenerative diseases not related to TDP-43 may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to earlier diagnosis and targeted therapies for patients with FTLD-TDP.

How similar studies have performed: Previous research has shown promise in understanding neurodegenerative diseases through similar interdisciplinary approaches, indicating potential for success in this novel investigation.

Where this research is happening

Stanford, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.